Ketonal (Ketoprofen)

Ketoprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels at the site of application, the drug diminishes the inflammatory cascade, reduces swelling, and lessens the transmission of pain signals.

The appropriate amount of Ketonal is determined by the prescribing healthcare professional based on the patient’s condition, age, and response. The prescriber will specify the quantity of gel or cream to apply, the frequency of application, and the duration of therapy.

Safety of topical ketoprofen during pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Ketonal.

To request Ketonal, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ketonal contains ketoprofen, which offers a broad COX‑1/COX‑2 inhibition profile. Compared with diclofenac or ibuprofen gels, ketoprofen may provide faster onset of pain relief for some patients, but individual response varies. Choice of product should consider efficacy, tolerability, and physician recommendation.

Ketonal should be stored below 25 °C in its original container, protected from moisture, direct sunlight, and excessive heat. Keep the packaging sealed when not in use to maintain product stability and prevent contamination.

Ketonal is applied topically to clean, dry skin over the affected area. The prescriber will advise the amount (e.g., a thin film or specific dose) and frequency, typically 2‑4 times daily. Hands should be washed after application, and the treated area should not be covered with occlusive dressings unless directed.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic NSAID toxicity leading to gastrointestinal bleeding, renal impairment, or cardiovascular events. Patients should seek immediate medical attention if they notice signs of a serious reaction.

Ketonal should be avoided by individuals with known hypersensitivity to ketoprofen or any NSAID, those with active gastrointestinal ulceration, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment unless specifically directed by a physician.